---
annotations:
- type: Pathway Ontology
  value: Leishmaniasis pathway
authors:
- ReactomeTeam
- DeSl
description: Macrophages specializing in tissue repair or associated with a Th2-type
  immune response are more permissive to infection with leishmania, since their defense
  mechanisms are not very efficient in eliminating the parasite and can contribute
  to its persistence (Lee et al. 2018).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9662851
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4993
- /instance/WP4993
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4993.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Macrophages specializing in tissue repair or associated with a Th2-type
    immune response are more permissive to infection with leishmania, since their
    defense mechanisms are not very efficient in eliminating the parasite and can
    contribute to its persistence (Lee et al. 2018).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9662851
    Reactome].
  keywords:
  - 'p-6Y-SYK '
  - PKA tetramer:4xcAMP
  - H2O
  - 'RXFP1 '
  - PI(4,5)P2
  - 'ADCY8 '
  - 'GNB3 '
  - cAMP:PKA regulatory
  - 'GNG10 '
  - '5HT '
  - IL10
  - 'HTR7 '
  - 'MC5R '
  - PKA catalytic
  - 'ADCY1 '
  - CREB1
  - Heterotrimeric
  - 'TAAR9 '
  - 'LCHA '
  - 'Ig kappa chain V-I region Daudi '
  - 'Lma amastigote surface '
  - 'IGLV3-22(1-?) '
  - 'TAAR8 '
  - 'IGLV1-36(1-?) '
  - complex
  - gene
  - CALM1
  - 'Ig heavy chain V-III region TRO '
  - Gs:Heterotrimeric
  - AHCYL1:NAD+:ITPR1:I(1,4,5)P3 tetramer
  - 'Ig kappa chain V-II region FR '
  - IgG:Lma antigens
  - 'Mg2+ '
  - 'NAd '
  - tetramer
  - CYSLTR1,CYSLTR2
  - 'ADCY6 '
  - 'CRHR2 '
  - 'DPEP2 '
  - 'GNAS2 '
  - 'Ig lambda chain V-II region NEI '
  - 'ADCYAP1R1 '
  - Glucocorticoid, IL6,
  - Src family kinases
  - ATP
  - 'IGHV(1-?) '
  - 'p-Y160,Y171-CD3G '
  - 'Hist '
  - 'GLP2R '
  - surface:p-FCGR3A:p-6Y-SYK:p-3Y-PLCG
  - PLK2, MAPK14
  - 'ADRB3 '
  - 'Ig lambda chain V-II region MGC '
  - 'Ig lambda chain V-I region HA '
  - 'GNB5 '
  - 'PTGDR '
  - 'Ca2+ '
  - Adenylate cyclase
  - 'MC1R '
  - 'SRC-1 '
  - GTP
  - 'p-6Y-CD247 '
  - 'ADCY9 '
  - 'IGKV3D-20 '
  - 'ADRB1 '
  - Lma amastigote
  - ADAM17(215-827):Zn2+
  - CD163 gene
  - 'RLN2(162-185) '
  - 'IGLC2 '
  - LTC4
  - 'p-T180,Y182-MAPK14 '
  - 'GGT1(1-380) '
  - 'IL10 '
  - 'Ig kappa chain V-I region HK101 '
  - Zn2+
  - 'Ig lambda chain V-III region SH '
  - 'Ig kappa chain V region EV15 '
  - cyclase
  - 'Ig lambda chain V-IV region Hil '
  - 'PI(3,4,5)P3 '
  - 'IGLV5-45(1-?) '
  - 'PGD2 '
  - 'Ig kappa chain V-I region AU '
  - 'IGLV(23-?) '
  - IL6
  - 'ADCY5 '
  - 'IGLC6 '
  - 'GNAZ '
  - IgG:LPG1G2
  - 'POMC(217-234) '
  - 'Ig kappa chain V-I region BAN '
  - 'PTGIR '
  - 'GPHA2 '
  - 'IgH  heavy chain V-III region VH26 precursor '
  - 'ADM2(19-153) '
  - 'IGLV1-40(1-?) '
  - 'IGLV10-54(1-?) '
  - 'LHCGR '
  - 'Ig lambda chain V-I region VOR '
  - 'IGLV2-33(1-?) '
  - antigens:FCGR3A:p-CD3 dimers
  - IgG
  - p-S133-CREB1:IL6
  - 'Constitutively active orphan GPCRs '
  - 'Ig heavy chain V-III region BUT '
  - 'cAMP '
  - 'TAAR3 '
  - 'INSL3(106-131) '
  - 'GTP '
  - (Mg2+ cofactor)
  - 'FSHB '
  - 'Ig lambda chain V-III region LOI '
  - 'ADCY2 '
  - 'TSHB '
  - LTD4
  - 'IGLV4-60(1-?) '
  - 'PTHLH '
  - 'RLN2(25-53) '
  - 'PLCG2 '
  - 'VIP(125-152) '
  - p-PLCG
  - ADAM17
  - 'RAMP2 '
  - 'POMC(138-176) '
  - 'CYSLTR2 '
  - G-protein beta-gamma
  - DAGs
  - 'GPR39 '
  - 'LHB '
  - 'CRH '
  - 'LYN '
  - I(1,4,5)P3
  - 'GDP '
  - 'NPSR1 '
  - 'Ig lambda chain V-VI region AR '
  - ADORA2B:Ade-Rib:Heterotrimeric G-protein Gs:GTP
  - ADP
  - 'PTH1R '
  - (SFKs)
  - LPG1G2
  - 'IGKV4-1(21-?) '
  - 'ADORA2B '
  - 'RAMP1 '
  - 'GNG12 '
  - 'GIP(52-93) '
  - 'Ig heavy chain V-III region CAM '
  - 'ArgN-GCG(98-127) '
  - 'PTGER4 '
  - 'Ig lambda chain V-II region BOH '
  - ADAM17(1-214)
  - 'ADRB2 '
  - 'IGLV7-43(1-?) '
  - 'IGHG4 '
  - G-protein Gs
  - 'PRKX '
  - 'IAPP(34-70) '
  - 'PEA '
  - catalytic subunits
  - 'PTH2R '
  - 'IGLC3 '
  - 'HCK '
  - 'GGT1(381-569) '
  - IgG:Lma amastigote
  - 'FCGR3A '
  - 'glucocorticoid '
  - subunit
  - 'PRKAR1A '
  - 'VIPR1 '
  - (s):GTP:Adenylate
  - 'CD3G '
  - MYH9
  - (z):GTP:Adenylate
  - PRKACA,(PRKACB,PRKACG,PRKX)
  - 'HTR4 '
  - 'HRH2 '
  - 'ADCY7 '
  - antigens:FCGR3A:CD3
  - 'IGLV7-46(1-?) '
  - 'IGKC '
  - dimers
  - 'GCG(146-178) '
  - 'CALCA(83-119) '
  - 'VIPR2 '
  - 'IGLV3-16(1-?) '
  - 'Ig heavy chain V-I region HG3 '
  - p-S133-CREB1
  - 'Ig heavy chain V-II region WAH '
  - 'PRKACB '
  - 'Ade-Rib '
  - sCD163:MYH9
  - p-S,T-ADAM17(215-827):Zn2+
  - 'GHRH '
  - 'IGHG2 '
  - 'FCGR1A '
  - surface
  - Gly
  - LTE4
  - 'Ig lambda chain V-I region NEWM '
  - 'p-S133-CREB1 '
  - 'TAAR2 '
  - 'FGR '
  - 'GNB2 '
  - ITPR:I(1,4,5)P3
  - 'ATP '
  - 'IGLV11-55(1-?) '
  - 'Ig kappa chain V-III region B6 '
  - 'TSHR '
  - 'sCD163 '
  - FCGRIIIA:CD3G/CD3Z
  - 'HTR6 '
  - cAMP
  - 'IGLV4-69(1-?) '
  - 'AHCYL1 '
  - 'Ig kappa chain V-III region VG '
  - (inactive)
  - 'IGHV7-81(1-?) '
  - 'Ig heavy chain V-I region EU '
  - PLC gamma1,2
  - Protein Kinase A,
  - 'NAD+ '
  - 'Ig lambda chain V-IV region Kern '
  - 'IGLV8-61(1-?) '
  - 'FYN '
  - 'PRKAR2A '
  - 'IGKV2D-30 '
  - 'IGLV2-11(1-?) '
  - Ca2+
  - IgG-Ag:p-FCGRs:p-6Y-SYK:PLCG
  - LTC4:CyslTR1,2
  - 'MC2R '
  - 'Ig heavy chain V-III region KOL '
  - 'Ig lambda chain V-I region NEW '
  - 'PRKAR1B '
  - 'IGHG3 '
  - 'RLN3(26-52) '
  - 'CDCA '
  - PI(3,4,5)P3
  - 'GNG4 '
  - CD163
  - CALM1:4xCa2+
  - 'IGLV5-37(1-?) '
  - 'GNG7 '
  - 'IGLV3-27(1-?) '
  - 'GNAI2 '
  - 'Ig heavy chain V-III region WEA '
  - 'GNAI1 '
  - 'I(1,4,5)P3 '
  - 'IGKV1-5(23-?) '
  - surface:p-FCGR3As:p-6Y-SYK:PLCG
  - 'DPEP3 '
  - 'GLP1R '
  - 'PRKACA '
  - 'P2RY11 '
  - 'Ig kappa chain V-II region Cum '
  - 'Ig kappa chain V-I region Wes '
  - (i):GTP:Adenylate
  - antigens:FCGR3A:p-CD3 dimers:SYK
  - Ade-Rib
  - 'GGT5(1-387) '
  - 'Ig heavy chain V-III region BRO '
  - 'Ig kappa chain V-II region RPMI 6410 '
  - 'GNG2 '
  - 'GNAI3 '
  - 'ADR '
  - L-Glu
  - 'GNAS1 '
  - IP3 receptor
  - 'Zn2+ '
  - 'SCT '
  - p-S133-CREB1:IL10
  - 'MC3R(1-360) '
  - G alpha (s):GTP
  - 'TAAR1 '
  - 'IGLV4-3(1-?) '
  - 'IGKV2-28 '
  - 'IL10 gene '
  - 'ADCYAP1(132-158) '
  - 'GCG(53-81) '
  - 'ADORA2A '
  - 'Ig lambda chain V-IV region Bau '
  - 'FSHR '
  - 'PRKAR2B '
  - IL6 gene
  - 'Ig kappa chain V-I region Gal '
  - 'GHRHR '
  - PPi
  - 'Ig heavy chain V-II region OU '
  - 'Ig heavy chain V-III region JON '
  - 'ADAM17(215-827) '
  - 'GNG3 '
  - 'CD247-1 '
  - 'PLCG1 '
  - 'GNB4 '
  - 'DA '
  - 'IGLV3-12(1-?) '
  - 'PGI2 '
  - antigens:FCGR3A:p-CD3 dimers:p-6Y-SYK
  - 'ADM(95-146) '
  - 'MC4R '
  - IgG:Lma
  - 'RAMP3 '
  - iRHOM2
  - 'p-4Y-PLCG1 '
  - 'Ig heavy chain V-II region NEWM '
  - 'IGLV2-23(1-?) '
  - SYK
  - 'GNGT2 '
  - 'IL6 '
  - 'IGHV1-2 '
  - 'ADCYAP1(132-169) '
  - 'Ig heavy chain V-II region MCE '
  - 'Ig heavy chain V-II region ARH-77 '
  - 'GPHB5 '
  - 'DRD1 '
  - 'AVPR2 '
  - 'IGLC1 '
  - 'INSL3(21-55) '
  - 'CALCR '
  - 'ITPR2 '
  - 'IGKV1-12 '
  - 'GNG13 '
  - 'GNG8 '
  - 'CRHR1 '
  - 'MYH9 '
  - 'CYSLTR1 '
  - 'IGLV2-18(1-?) '
  - 'SCTR '
  - 'GPBAR1 '
  - 'AVP(20-28) '
  - complexes that
  - 'IGLV3-25(1-?) '
  - DPEP1,2,3 dimers
  - G alpha
  - 'GNG5 '
  - 'CALCRL '
  - 'Ig lambda chain V-II region TOG '
  - 'ADCYAP1(82-129) '
  - G-protein alpha
  - 'CALM1 '
  - 'Ig kappa chain V-III region POM '
  - 'ADCY3 '
  - 'CALCB(82-118) '
  - sCD163
  - 'PTH '
  - 'Ig heavy chain V-III region DOB '
  - 'LPG1G2 '
  - 'Ig kappa chain V-I region DEE '
  - 'IL6 gene '
  - clustered
  - 'IGKVA18(21-?) '
  - IgG:Leishmania
  - 'SYK '
  - 'CCA '
  - 'POMC(138-150) '
  - 'Ig kappa chain V-I region AG '
  - 'ADCY4 '
  - 'TAAR6 '
  - ADORA2B:Ade-Rib
  - 'p-Y753,Y759,Y1217-PLCG2 '
  - 'NPS '
  - 'DPEP1 '
  - Ligand:GPCR
  - FURIN
  - G-betagamma
  - 'p-Y288,Y304-FCGR2A '
  - 'Antigen '
  - activate
  - 'ITPR1 '
  - 'POMC(77-87) '
  - 'PGE2 '
  - 'ITPR3 '
  - 'RLN3(119-142) '
  - ADORA2B
  - 'IGLV1-44(1-?) '
  - 'IGLC7 '
  - 'LTC4 '
  - PKA tetramer
  - homotetramer
  - 'PTH2(62-100) '
  - 'GNG11 '
  - 'IGHG1 '
  - 'RXFP2 '
  - Ade-Rib:ADORA2B:Heterotrimeric G-protein Gs:GDP
  - 'DRD5 '
  - GDP
  - 'PRKACG '
  - IL10 gene
  - 'GNB1 '
  - GGT1, 5 dimers
  - 'GNAT3 '
  - 'Ig lambda chain V region 4A '
  - 'GGT5(388-586) '
  - 'DCA '
  - 'CGA '
  - ADAM17(215-827)
  - 'GNGT1 '
  - CD163(1051-1156)
  - 'GIPR '
  - 'GLP-1 (7-37) '
  - GGT1 dimer
  - 'PTGER2 '
  - 'PLK2 '
  - 'TAAR5 '
  - 'YES1 '
  license: CC0
  name: Anti-inflammatory response favouring Leishmania parasite infection
seo: CreativeWork
title: Anti-inflammatory response favouring Leishmania parasite infection
wpid: WP4993
---